WallStreetZenWallStreetZen

NASDAQ: RNA
Avidity Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for RNA

Based on 15 analysts offering 12 month price targets for Avidity Biosciences Inc

Min Forecast
$55.00-23.43%
Avg Forecast
$69.40-3.38%
Max Forecast
$96.00+33.65%

Should I buy or sell RNA stock?

Based on 15 analysts offering ratings for Avidity Biosciences Inc.

Buy
Strong Buy
5 analysts 33.33%
Buy
2 analysts 13.33%
Hold
8 analysts 53.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RNA stock forecasts and price targets.

RNA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-11
lockedlocked$00.00+00.00%2025-10-29
lockedlocked$00.00+00.00%2025-10-28
lockedlocked$00.00+00.00%2025-10-27
lockedlocked$00.00+00.00%2025-10-27
Bernstein
Bottom 13%
13
HoldDowngrades$72.00+0.24%2025-10-27
Needham
Top 1%
100
HoldDowngrades$65.00-9.51%2025-10-27
HC Wainwright & Co.
Top 22%
79
HoldDowngrades$72.00+0.24%2025-10-27
Evercore ISI Group
Top 1%
100
BuyMaintains$65.00-9.51%2025-09-22
Roth Capital
Top 9%
92
Strong BuyInitiates Coverage On$62.00-13.69%2025-09-17

1 of 2

Forecast return on equity

Is RNA forecast to generate an efficient return?

Company
-9.82%
Industry
252.48%
Market
227.91%
RNA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RNA forecast to generate an efficient return on assets?

Company
-8.68%
Industry
90.65%
RNA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RNA earnings per share forecast

What is RNA's earnings per share in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
-$4.61
Avg 2 year Forecast
-$5.36
Avg 3 year Forecast
-$4.30

RNA revenue forecast

What is RNA's revenue in the next 3 years based on estimates from 15 analysts?

Avg 1 year Forecast
$17.9M-14.3%
Avg 2 year Forecast
$24.5M+17.62%
Avg 3 year Forecast
$381.0M+1,725.57%
RNA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RNA revenue growth forecast

How is RNA forecast to perform vs Biotechnology companies and vs the US market?

Company
144.77%
Industry
101.28%
Market
25.61%
RNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RNA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RNA$71.83$69.40-3.38%Buy
EXEL$40.88$45.82+12.09%Buy
BMRN$53.31$84.64+58.76%Strong Buy
JAZZ$167.50$204.46+22.06%Strong Buy
MRNA$29.46$30.30+2.85%Hold
View Top Biotech Stocks

Avidity Biosciences Stock Forecast FAQ

Is Avidity Biosciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 15 Wall Street analysts covering (NASDAQ: RNA) stock is to Buy RNA stock.

Out of 15 analysts, 5 (33.33%) are recommending RNA as a Strong Buy, 2 (13.33%) are recommending RNA as a Buy, 8 (53.33%) are recommending RNA as a Hold, 0 (0%) are recommending RNA as a Sell, and 0 (0%) are recommending RNA as a Strong Sell.

If you're new to stock investing, here's how to buy Avidity Biosciences stock.

What is RNA's earnings growth forecast for 2025-2027?

(NASDAQ: RNA) Avidity Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 43.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.6%.

Avidity Biosciences's earnings in 2025 is -$549,787,000.On average, 16 Wall Street analysts forecast RNA's earnings for 2025 to be -$694,072,738, with the lowest RNA earnings forecast at -$710,255,313, and the highest RNA earnings forecast at -$617,017,163. On average, 16 Wall Street analysts forecast RNA's earnings for 2026 to be -$807,953,464, with the lowest RNA earnings forecast at -$964,234,343, and the highest RNA earnings forecast at -$670,974,147.

In 2027, RNA is forecast to generate -$647,287,920 in earnings, with the lowest earnings forecast at -$714,685,179 and the highest earnings forecast at -$468,300,206.

What is RNA's revenue growth forecast for 2025-2027?

(NASDAQ: RNA) Avidity Biosciences's forecast annual revenue growth rate of 144.77% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 101.28%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.61%.

Avidity Biosciences's revenue in 2025 is $20,868,000.On average, 15 Wall Street analysts forecast RNA's revenue for 2025 to be $2,694,534,294, with the lowest RNA revenue forecast at $797,376,027, and the highest RNA revenue forecast at $4,809,569,685. On average, 15 Wall Street analysts forecast RNA's revenue for 2026 to be $3,698,185,412, with the lowest RNA revenue forecast at $0, and the highest RNA revenue forecast at $10,346,903,203.

In 2027, RNA is forecast to generate $57,401,430,672 in revenue, with the lowest revenue forecast at $15,415,635,164 and the highest revenue forecast at $90,607,350,694.

What is RNA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: RNA) forecast ROA is -8.68%, which is lower than the forecast US Biotechnology industry average of 90.65%.

What is RNA's Price Target?

According to 15 Wall Street analysts that have issued a 1 year RNA price target, the average RNA price target is $69.40, with the highest RNA stock price forecast at $96.00 and the lowest RNA stock price forecast at $55.00.

On average, Wall Street analysts predict that Avidity Biosciences's share price could fall to $69.40 by Nov 11, 2026. The average Avidity Biosciences stock price prediction forecasts a potential downside of 3.38% from the current RNA share price of $71.83.

What is RNA's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: RNA) Avidity Biosciences's current Earnings Per Share (EPS) is -$4.19. On average, analysts forecast that RNA's EPS will be -$4.61 for 2025, with the lowest EPS forecast at -$4.71, and the highest EPS forecast at -$4.10. On average, analysts forecast that RNA's EPS will be -$5.36 for 2026, with the lowest EPS forecast at -$6.40, and the highest EPS forecast at -$4.45. In 2027, RNA's EPS is forecast to hit -$4.30 (min: -$4.74, max: -$3.11).

What is RNA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: RNA) forecast ROE is -9.82%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.